MACH-1
DEAD

Serial Number

90033606

Owner

Orlance, Inc.

Attorney

Connie L. Ellerbach

Filing Date

Jul 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MACH-1 Trademark

Serial Number: 90033606

MACH-1 is a trademark filed by Orlance, Inc. on July 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Orlance, Inc. (5 trademarks)

1124 Columbia St., Suite 300
Seattle, WA 98104

Entity Type: 03

Trademark Details

Filing Date

July 2, 2020

Registration Date

Not Registered

Published for Opposition

May 18, 2021

Goods & Services

vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; pharmaceutical preparations and substances for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes

medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes

research and development of vaccines; research and development of medicines; medical research; scientific research; clinical research; all in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 19, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 19, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jan 18, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 18, 2024 AITU
SOU EXTENSION 5 FILED
Dec 29, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 29, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jun 16, 2023 EX4G
SOU EXTENSION 4 FILED
Jun 16, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 16, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 11, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 11, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 11, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 5, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 1, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 1, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 11, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 11, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 11, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 13, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 18, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 18, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 8, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 8, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2020 NWOS
NEW APPLICATION ENTERED
Jul 6, 2020 NWAP